Furthermore, we evaluated the Ki-67 in pre-treatment biopsy specimens, due to the fact that tissue degeneration following chemotherapy often makes it difficult to identify Ki-67-positive tumor cells. This evidence concerns the gene MKI67 and neoplasm.